PAVmed’s Veris Health Appoints Gary Manning as President By Investing.com

PAVmed (NASDAQ:) Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed“), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majority-owned digital health subsidiary Veris Health Inc. (“Veris”), today announced the appointment of Gary Manning to the newly created position of President, Veris Health. Mr. Manning reports directly to Lishan Aklog, M.D., PAVmed’s Chairman & Chief Executive Officer and Veris’ Executive Chairman.

“We are very pleased to welcome Gary to Veris and to the PAVmed family,” said Dr. Aklog. “Gary is an accomplished medical technology executive who shares our deep passion for developing and commercializing highly innovative solutions for the benefit of patients and their physicians. He has had a successful career, spanning three decades, including leading companies in the medical device, wearable, and digital health arenas and commercializing products in the global market. We look forward to leveraging Gary’s expertise and strategic insight to drive commercialization of our Veris Cancer Care Platform™, as well as guide the company through near-term development, regulatory and commercialization milestones for our implantable cardiac and physiologic monitor.”

“I am both thrilled and honored by the opportunity to lead Veris at such an exciting time in the company’s life cycle and eager to contribute further to the commercial and developmental successes already delivered by this incredibly talented team,” said Mr. Manning. “Throughout my career, I have been drawn to opportunities that are rooted in cutting-edge solutions which provide meaningful improvements in patient care. I believe the Veris Cancer Care Platform and Veris’ implantable technology under development are such solutions. Feedback from my early engagement with Veris clients squarely aligns with our confidence in the vast potential for these technologies to enhance personalized cancer care.”